THE BABRAHAM INSTITUTE
The Babraham Institute undertakes world-leading innovative research into the molecular mechanisms that underlie normal cellular processes and functions throughout development and the ageing process. Much of the Institute's research involves collaborations with other research institutions and organisations worldwide. The Institute also offers first class PhD and postdoctoral training programmes.
Objects
THE WORLD-WIDE ADVANCEMENT OF EDUCATION IN BIOLOGICAL SCIENCE
Financial health, per its FY2026 accounts
The accounts state that the group's total reserves decreased from £146m to £137m, with unrestricted revenue reserves falling by £4.7m. The trustees note that the current funding model is not sufficient to meet costs and that the institute expects net cash outflows, relying on confirmed UKRI-BBSRC funding and the release of restricted funds to maintain going concern status through 2028.
What the accounts disclose
“£180,000 - £189,999 2026 No 1”
“The Group's target level of reserves of £18.5M compares to free reserves of £13.1M at year end.” — page 25
“The Babraham Institute is dependent on various funding sources including UKRI-BBSRC to meet its liabilities as they fall due within future years. The current funding model is not sufficient to meet costs, and the institute is expecting net cash outflows for the going concern period.” — page 25
“The charity has two trading subsidiaries: Babraham Research Campus Limited (BRCL) (Registered in England and Wales number 03241492) and Babraham Institute Enterprise Limited (BIE) (Registered in England and Wales number 06331858)” — page 4
Year-over-year changes
- Going concern: no going-concern doubt (FY2025) → going-concern doubt noted (FY2026).
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2026
- Employees paid over £60,000: 47 (£60,001–£70,000: 16; £70,001–£80,000: 11; £80,001–£90,000: 9; £90,001–£100,000: 3; £100,001–£110,000: 1; £110,001–£120,000: 1; £120,001–£130,000: 1; £130,001–£140,000: 3; £150,001–£200,000: 2)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/03/2025
- Employees paid over £60,000: 48 (£60,001–£70,000: 19; £70,001–£80,000: 10; £80,001–£90,000: 9; £90,001–£100,000: 1; £100,001–£110,000: 1; £120,001–£130,000: 2; £130,001–£140,000: 3; £150,001–£200,000: 3)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/03/2024
- Employees paid over £60,000: 43 (£60,001–£70,000: 17; £70,001–£80,000: 11; £80,001–£90,000: 4; £90,001–£100,000: 2; £100,001–£110,000: 2; £110,001–£120,000: 1; £120,001–£130,000: 2; £130,001–£140,000: 2; £150,001–£200,000: 2)
- Has a trading subsidiary
In the news
- Model of womb lining enables Babraham Institute researchers to ‘listen in’ as embryo implants
- Babraham Institute Enterprise welcomes four new Board Members to its Board
- PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development - News-Medical
- BBSRC invests £48 million in lifelong health research at Babraham Institute
- Babraham Institute receives £48M strategic investment from BBSRC for a four-year programme of work to promote lifelong health
- Babraham Institute collaboration reveals reason for cell fate decision in human embryonic development
- PlaqueTec and Babraham Institute partner for treatment of coronary heart disease
- The projects that earned Pioneer awards for four group leaders at the Babraham Institute
Leadership, per the charity’s website
- Professor Sir Jim Smith — Interim Director
- James Smith — Institute Director
- Simon Jones — Chief Operating Officer
- Martin Turner — Associate Director
Funders the charity credits
- European Horizon2020 programme
- European Science with and for Society H2020 programme
Property (HM Land Registry)
Structured financials (annual return, FY ending 31/03/2026)
Trustees
- Alexandra Zoe Pygall
- Dr John Wells
- Graham Peter Allen
- John Macey
- Professor Gordon Brown FRS
- Professor Helen Walden
- Professor Linda Partridge FRS
- Professor Paul Lehner FRS
- Professor Petra Hajkova
- TIMOTHY LIVETT
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2026 | £48.0m | £58.4m |
| 31/03/2025 | £47.5m | £55.1m |
| 31/03/2024 | £46.7m | £49.6m |
| 31/03/2023 | £41.2m | £46.4m |
| 31/03/2022 | £40.5m | £41.9m |
Common questions
Is THE BABRAHAM INSTITUTE financially healthy?
Per its FY2026 accounts: The accounts state that the group's total reserves decreased from £146m to £137m, with unrestricted revenue reserves falling by £4.7m. The trustees note that the current funding model is not sufficient to meet costs and that the institute expects net cash outflows, relying on confirmed UKRI-BBSRC funding and the release of restricted funds to maintain going concern status through 2028. Its FY2026 accounts were audited by Grant Thornton UK LLP.
What does the highest-paid employee of THE BABRAHAM INSTITUTE earn?
Per its FY2026 accounts, the highest-paid employee was in the £180,000 - £189,999 band.
Who funds THE BABRAHAM INSTITUTE?
Funders whose own accounts filings name THE BABRAHAM INSTITUTE as a grant recipient include THE LISTER INSTITUTE OF PREVENTIVE MEDICINE, THE EVELYN TRUST, THE BRITISH MASS SPECTROMETRY SOCIETY.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE LISTER INSTITUTE OF PREVENTIVE MEDICINE | FY2020 | £250k | Lister Prize Fellowship (Dr Hayley Sharpe) |
| THE EVELYN TRUST | FY2021 | £38k | Research using RNA sequencing to understand poor vaccine responses in older people |
| THE BRITISH MASS SPECTROMETRY SOCIETY | FY2022 | £2k | Grants, Provision of grants to assist members to present their research at both national and international scientific meetings |
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| UK government | 31/08/2023 | £42k | Systematically defining the T cell signalling network of the phosphatase CD45 |
| UK government | 17/07/2023 | £15k | Tuning the signal protein citrullination as a mediator of cell signalling |
| UK government | 17/07/2023 | £15k | Does chromosomal fragmentation cause premature ageing |
| UK government | 03/07/2023 | £75k | Re-wiring the metabolic regulatory system to promote a healthy ageing trajectory |
| UK government | 24/04/2023 | £19k | Open Access Block Award 2023 - Babraham Institute |
| UK government | 08/08/2022 | £95k | PADIngton - The role of protein citrullination in the regulation of cell fate |
| UK government | 08/08/2022 | £259k | Molecular and metabolic pathways controlling developmental timing. TempoReg |
| UK government | 31/07/2022 | £28k | Reprogramming cells from the outside in |
| UK government | 31/07/2022 | £28k | Interrogating the function of deubiquitylases |
| UK government | 31/07/2022 | £28k | Unpicking the role of cellular stress responses in the efficacy of novel senolytic agents |
| UK government | 26/07/2022 | £28k | Understanding the impact of MAPT induced nuclear changes in human cells |
| UK government | 26/07/2022 | £28k | Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes |
| UK government | 26/07/2022 | £28k | mRNA selective translational control required for B cell proliferation |
| UK government | 12/07/2022 | £345k | (Lost-Tfh) Lost in space: How spatial dysregulation of T follicular helper cells impairs vaccine responses in ageing |
| UK government | 15/06/2022 | £249k | Mechanisms restraining the accumulation of antibody secreting cells |
| UK government | 01/12/2021 | £282k | Regulation of T cell differentiation by stimulation strength |
| UK government | 23/08/2021 | £149k | Impaired selection of germinal centre B cells in ageing diminishes the quality of antibody mediated immunity upon vaccination |
| UK government | 07/07/2021 | £28k | Functional Regulatory Variation in Stimulus Responsive Myeloid Cell Lineage Enhancers |
| UK government | 29/06/2021 | £28k | Does inappropriate DNA replication provide a mechanism for acquisition of drug resistance |
| UK government | 17/03/2021 | £235k | Epigenetic regulation of lineage competence in human pluripotent stem cells |
| UK government | 06/07/2020 | £27k | Exploring the signalling mechanism of the tyrosine phosphatase SHP2 |
| UK government | 08/06/2020 | £154k | Generation of an In Vivo Senescent Cell Atlas: Across the life-course and in pathology |
| UK government | 25/03/2020 | £173k | Defining the gene regulatory mechanisms controlling the entry of human cells into naive pluripotency |
| UK government | 20/05/2019 | £7k | Unbiased determination of BRAF variants modulating BRAF - CRAF dimerisation and MAPK signalling |
| UK government | 30/04/2019 | £29k | Investigating the targets and biological roles of the deubiquitylase USP43 |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| JOHN INNES FOUNDATION | 1 | £1.1m |
| BREAST CANCER NOW | 1 | £249k |
| JIDCUK CHARITABLE TRUST | 1 | £62k |
Charities like this
- EARLHAM INSTITUTE
- QUADRAM INSTITUTE BIOSCIENCE
- INSTITUTE OF BIOMEDICAL SCIENCE
- INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE BABRAHAM INSTITUTE | £48.0m | £180,000 - £189,999 | — | below | — | noted |
| EARLHAM INSTITUTE | £14.1m | — | — | above | — | no doubt |
| QUADRAM INSTITUTE BIOSCIENCE | £20.4m | — | — | above | — | no doubt |
| INSTITUTE OF BIOMEDICAL SCIENCE | £5.7m | — | — | above | — | no doubt |
| INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE | £68k | — | 0 | unclear | — | no doubt |